Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Sanguinaria Can
Brand Name
Sanguinaria Can
Generic Name
Sanguinaria Can
Active Ingredient
Sanguinaria Canadensis RootCategory
Non-Standardized Food Allergenic Extract [EPC]
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 1 [hp_X]/mL | LIQUID | ORAL | 15631-2940 |
Detailed information about Sanguinaria Can
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Sanguinaria Can, you must consult a qualified healthcare professional.
Sanguinaria Canadensis Root is a complex botanical extract primarily classified as a non-standardized plant allergenic extract, used in diagnostic immunology and research into hormonal and adrenergic pathways.
Dosage for Sanguinaria Canadensis Root is highly specialized and must be administered by a trained healthcare professional, typically an allergist or immunologist. There is no "standard" dose like one would find with an over-the-counter medication.
Sanguinaria Canadensis Root allergenic extracts are generally not recommended for infants. In older children, the use is similar to adults but requires extreme caution.
There are no specific dose adjustment guidelines for diagnostic testing in patients with renal impairment, as the systemic exposure is low. However, in cases of systemic administration or high-dose research, renal clearance must be monitored, and doses may need to be reduced by 25-50% in patients with a GFR below 30 mL/min.
Because the liver is the primary site for the metabolism of Sanguinaria alkaloids, patients with severe hepatic impairment (Child-Pugh Class C) should be monitored closely for signs of toxicity. Dose reductions may be necessary if systemic absorption is expected.
Elderly patients (65+) may be more sensitive to the adrenergic effects of Sanguinaria Canadensis Root. Healthcare providers should use the lowest effective concentration for testing and monitor cardiovascular parameters, especially in patients with pre-existing hypertension or arrhythmia.
Sanguinaria Canadensis Root extracts are almost exclusively administered by healthcare professionals in a clinical setting.
Since Sanguinaria Canadensis Root is typically used for one-time diagnostic tests or specific clinical procedures, missed doses are rare. If a scheduled testing appointment is missed, it should be rescheduled as soon as possible. There is no "catch-up" dose required.
An overdose of Sanguinaria Canadensis Root can occur if too much extract is injected or if it is accidentally ingested.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not attempt to administer this substance to yourself or others without medical supervision.
Most side effects associated with Sanguinaria Canadensis Root are localized to the site of administration, especially when used for diagnostic testing.
These effects typically resolve within 2 to 24 hours without further intervention.
> Warning: Stop the procedure and call your doctor or emergency services immediately if you experience any of the following:
Long-term exposure to Sanguinaria Canadensis Root, particularly through oral or topical routes, is associated with significant risks:
While Sanguinaria Canadensis Root itself may not always carry a specific individual black box warning, the class of Allergenic Extracts to which it belongs does.
FDA Black Box Warning for Allergenic Extracts:
Report any unusual symptoms to your healthcare provider immediately. Do not ignore signs of a spreading rash or difficulty breathing.
Sanguinaria Canadensis Root is a potent pharmacological agent that must be handled with extreme care. It contains alkaloids that are cytotoxic (toxic to cells) and can cause significant tissue damage if used improperly. Patients must be aware that "natural" does not mean "safe" in the context of Bloodroot extracts.
As noted, Sanguinaria Canadensis Root falls under the general FDA black box warning for allergenic extracts. This warning emphasizes that administration can lead to anaphylactic shock. Facilities where this drug is administered must be equipped with emergency kits containing epinephrine, oxygen, and IV fluids. Patients should be observed for a minimum of 30 minutes post-injection, as most fatal reactions occur within this window.
If Sanguinaria Canadensis Root is used in a research or systemic capacity, the following monitoring is required:
Patients should not drive or operate heavy machinery for at least 1-2 hours after receiving an injection of Sanguinaria Canadensis Root. While the drug itself may not cause sedation, a systemic reaction or the stress of the procedure can lead to dizziness or fainting.
Alcohol should be avoided for 24 hours before and after administration. Alcohol can dilate blood vessels and may increase the rate of systemic absorption of the extract, potentially increasing the risk of a severe allergic reaction.
There is no known withdrawal syndrome associated with Sanguinaria Canadensis Root, as it is not typically used for chronic maintenance therapy. However, if a patient develops a severe reaction, the use of the extract must be permanently discontinued.
> Important: Discuss all your medical conditions, especially heart problems and asthma, with your healthcare provider before starting Sanguinaria Canadensis Root.
For each major interaction, the mechanism usually involves either competitive binding at the receptor level (e.g., estrogen receptors) or potentiation of the sympathetic nervous system. The clinical consequence is typically an increased risk of cardiovascular events or a failure of emergency treatments like epinephrine.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those for blood pressure or asthma.
Sanguinaria Canadensis Root must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
Patients allergic to Sanguinaria Canadensis Root may also react to:
> Important: Your healthcare provider will evaluate your complete medical history, including any history of fainting or severe allergies, before prescribing Sanguinaria Canadensis Root.
Sanguinaria Canadensis Root is generally classified as FDA Pregnancy Category C. This means that animal reproduction studies have not been conducted, and there are no adequate and well-controlled studies in humans.
It is unknown whether the alkaloids in Sanguinaria Canadensis Root pass into breast milk. However, many alkaloids are excreted in milk and could potentially affect a nursing infant. Because of the risk of toxicity, breastfeeding should be suspended for at least 24-48 hours after the administration of this extract.
Elderly patients are at increased risk for adverse effects from Sanguinaria Canadensis Root:
In patients with chronic kidney disease (CKD), the metabolites of Sanguinaria alkaloids may accumulate. While no specific GFR-based dosing is available for diagnostic tests, patients with Stage 4 or 5 CKD should be monitored for signs of systemic alkaloid toxicity, such as nausea and bradycardia.
Patients with cirrhosis or other forms of liver failure may have impaired metabolism of sanguinarine. In these patients, the half-life of the drug is likely extended. Use with extreme caution in patients with a Child-Pugh score of 7 or higher.
> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant or planning to become pregnant.
Sanguinaria Canadensis Root acts through several distinct molecular pathways. Its primary alkaloid, sanguinarine, is a benzophenanthridine alkaloid. It binds to and inhibits the Na+/K+-ATPase enzyme, which is critical for maintaining cellular osmotic balance and electrical gradients.
Furthermore, the extract interacts with the following:
| Parameter | Value |
|---|---|
| Bioavailability | <5% (Skin Prick); Variable (Oral) |
| Protein Binding | ~85-95% (Primarily Albumin) |
| Half-life | 2-4 hours (Alkaloid components) |
| Tmax | 0.5 - 1 hour (Post-injection) |
| Metabolism | Hepatic (Reduction to Dihydrosanguinarine) |
| Excretion | Renal 60%, Fecal 40% |
Sanguinaria Canadensis Root is classified as a Non-Standardized Plant Allergenic Extract. It shares this class with other botanical allergens like Ragweed or Oak extracts. However, its unique chemical profile gives it additional classifications as a hormonal and adrenergic modulator, distinguishing it from simpler pollen extracts.
Common questions about Sanguinaria Can
Sanguinaria Canadensis Root, also known as Bloodroot, is primarily used in clinical settings as a diagnostic allergenic extract to identify patients with specific plant allergies. It is also utilized in pharmacological research due to its ability to interact with estrogen, progesterone, and adrenergic receptors. Historically, it was used in some dental products for plaque control, though this is no longer recommended due to safety concerns. In modern medicine, it is strictly a professional-use product for immunology and specialized research. It is never used as a first-line treatment for common illnesses.
The most common side effects occur at the site of administration and include redness, intense itching, and the formation of a raised wheal (a hive-like bump). Some patients may also experience a mild burning or stinging sensation immediately after the skin is tested. These reactions are usually normal and indicate that the body is responding to the allergen. In most cases, these localized symptoms disappear within 24 hours without any special treatment. If the redness spreads or you feel lightheaded, you should notify your healthcare provider immediately.
It is strongly advised to avoid alcohol for at least 24 hours before and after receiving a Sanguinaria Canadensis Root extract. Alcohol can cause blood vessels to widen (vasodilation), which may speed up the absorption of the extract into your bloodstream and increase the risk of a severe, body-wide allergic reaction. Furthermore, alcohol can mask the early signs of a reaction, such as dizziness or flushing, making it harder for doctors to treat you effectively. Always follow your doctor's pre-procedure instructions regarding food and drink. Staying hydrated with water is generally preferred.
Sanguinaria Canadensis Root is generally not recommended during pregnancy unless the diagnostic need is urgent. It is classified as FDA Category C, meaning there is insufficient data to guarantee its safety for the developing fetus. There are theoretical concerns that the alkaloids in the root could affect hormonal balance or cause uterine contractions. Most allergists will postpone non-essential allergy testing until after the patient has given birth. If you are pregnant or breastfeeding, you must discuss the risks and benefits thoroughly with your obstetrician and allergist before proceeding.
When used for allergy testing, Sanguinaria Canadensis Root works very quickly, with a localized skin reaction typically appearing within 15 to 20 minutes. This rapid onset is why patients are required to stay in the doctor's office for a short observation period following the test. If the extract is being studied for its hormonal or adrenergic effects, the onset can vary, but physiological changes often begin within 30 to 60 minutes of administration. The duration of the skin reaction is usually short-lived, fading significantly within a few hours. Systemic effects, if any, generally resolve within a day.
Since Sanguinaria Canadensis Root is almost always administered as a one-time diagnostic test or in a controlled clinical setting, there is no need for a tapering process. You do not "take" it like a daily pill, so stopping it suddenly is not an issue in the traditional sense. However, if you were using an oral or topical product containing Sanguinaria (which is generally discouraged), you should stop immediately and consult a doctor. There are no known withdrawal symptoms, but a doctor should evaluate any tissue damage or oral changes that may have occurred during use. Always follow professional medical advice regarding discontinuation.
Missing a dose of Sanguinaria Canadensis Root usually means missing a scheduled allergy testing appointment. If this happens, simply contact your doctor's office to reschedule the procedure. Because this is not a maintenance medication for a chronic condition, a missed dose does not pose an immediate health risk or require a "double dose" later. It is important, however, to eventually complete the testing if it is needed to manage your allergies or asthma. Ensure you follow any pre-test instructions, such as avoiding antihistamines, for your rescheduled appointment.
There is no clinical evidence to suggest that a one-time diagnostic use of Sanguinaria Canadensis Root causes weight gain. While the extract is classified as having Estrogen and Corticosteroid [EPC] properties—hormones often associated with weight changes—the amount used in testing is far too small to affect body weight. Chronic systemic exposure in a research setting could theoretically influence metabolism, but this has not been documented in human patients. If you experience sudden weight changes, they are likely due to other factors or medications, and you should discuss them with your healthcare provider.
Sanguinaria Canadensis Root has several significant drug interactions that your doctor must consider. It should generally not be used with beta-blockers, as they can interfere with the treatment of a severe allergic reaction. It may also interact with blood pressure medications, antidepressants (like MAOIs), and hormonal therapies due to its complex pharmacological profile. You must provide your healthcare provider with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you are currently taking. This allows them to safely manage your testing and avoid dangerous complications.
Sanguinaria Canadensis Root is a botanical extract rather than a synthetic drug, so the concept of "generic" vs. "brand name" is slightly different. It is produced by various specialized laboratories that manufacture allergenic extracts. While there may be multiple suppliers, these products are not interchangeable in the same way generic ibuprofen is for Advil. Each manufacturer's extract may have a different concentration or stabilization method. Your allergist will use a specific preparation that they are familiar with to ensure consistent results. It is not available for purchase by the general public at a pharmacy.
Other drugs with the same active ingredient (Sanguinaria Canadensis Root)